" About NCP Value and Values Market Opportunity Investment Focus Defining the Field Creating Value Power of Partnerships Managing Directors Principals Associates Accounting/Finance Operating Advisors Overview Current Portfolio Companies Historic Portfolio Companies		Enzymatic Therapy, Inc. Founded in 1981, Enzymatic Therapy is recognized as the highest quality manufacturer and distributor of proprietary premium natural medicines and nutritional supplements in its market. Enzymatic's mission is to improve the health of America by addressing core health issues, with therapeutic products tailored to the health condition of the individual and to help individuals throughout the world experience "What Better Feels Like." Enzymatic Therapy named Manufacturer of the Year by Nutrition Industry Executive magazine Click to read more... (6.4Mb PDF file) The company distributes to health food stores, independently owned pharmacy retailers and select mass merchandisers through its Enzymatic Therapy unit and to licensed health care practitioners through its Integrative Therapeutics Division. Its retail brands include Enzymatic Therapy and PhytoPharmica, while Tyler, PhytoPharmica professional, NF formulas and Vitaline are sold in the professional channel. As a leading private equity firm focused exclusively on consumer businesses that benefit from "Healthy Living and Aging" trends, North Castle was attracted to Enzymatic Therapy for its high quality, innovative products and focus in the rapidly growing and highly fragmented practitioner channel of the market. Enzymatic Therapy is widely recognized as the industry leader in innovation, quality and product efficacy. Throughout its history, the company has introduced proprietary first-to-market products and groundbreaking technologies. Enzymatic Therapy was the first company to introduce glucosamine sulfate, gingko biloba and many other products into the North American marketplace. The company was also the first in the United States to provide standardized active ingredients in its botanical products and to introduce phytozomes to aid consumers in absorbing active ingredients of ingested products. Recent product successes include Fiber Fusion, BP Manager and FlexAgility MAX. Enzymatic Therapy's product development staff employs rigorous quantitative and qualitative tests to design, identify, develop, validate and deliver the highest-quality and most effective natural medicines and dietary supplements. A distinguished scientific advisory board reviews new products before their introduction to the marketplace. The company manufacturers a majority of its products in its pharmaceutical-grade plant located in Green Bay, Wisconsin, and employs stringent quality-control procedures. North Castle has recruited a highly accomplished management team led by CEO Randy Rose, most recently the president and COO of Energizer Holdings North America and Europe, with previous general management and sales experience at Ralston Purina and Procter & Gamble. Mr. Rose and his team have been re-engineering sales and marketing into a high-performance integrated customer development group. This group is leveraging the company's unique product development capabilities to increase penetration in existing markets and seek out new distribution channels to pursue long-term growth. Websites www.enzy.com www.phytopharmica.com www.prevail.com www.integrativeinc.com
		The information on these pages is intended solely for the benefit of persons who might be aware of investment opportunities that would interest North Castle Partners. North Castle's services are provided only to a limited number of private investment funds; North Castle does not make its services available to the public.